JP Morgan Chase
YTEN

JP Morgan Chase’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

JP Morgan Chase’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$2 – 7981
2023
Q3 		– Hold
0
– – – 7412
2021
Q3 		– Sell
-65
Closed -$13K – 6906
2021
Q2 		$13K Buy
+65
New +$14.5K ﹤0.01% 6009

Other funds holding YTEN

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

JP Morgan Chase's YTEN Position: Q4 2023 in Review

JP Morgan Chase held its Yield10 Bioscience, Inc. Common Stock (YTEN) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7981.

JP Morgan Chase first reported a position in YTEN in Q2 2021 and has held it in 1 quarter since. The position peaked at $13K in Q2 2021. 17 funds tracked by Wall St. Rank hold YTEN as of Q4 2023.

  • JP Morgan Chase held 0 shares of Yield10 Bioscience, Inc. Common Stock worth $0 as of Q4 2023.
  • JP Morgan Chase left its Yield10 Bioscience, Inc. Common Stock share count unchanged in Q4 2023.
  • Yield10 Bioscience, Inc. Common Stock made up ﹤0.01% of JP Morgan Chase's portfolio in Q4 2023, its #7981 holding.
  • JP Morgan Chase first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2021 and has held it in 1 quarter since.
  • JP Morgan Chase's Yield10 Bioscience, Inc. Common Stock position peaked at $13K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.